Literature DB >> 30230078

Everyday life and mastocytosis from a patient perspective-a qualitative study.

Britt Jensen1,2, Sigurd Broesby-Olsen1,2, Carsten Bindslev-Jensen1,2, Dorthe S Nielsen3,4.   

Abstract

AIM: To investigate and gain knowledge about patients' perspectives on everyday life with mastocytosis and how they experience, understand and manage symptoms and challenges.
BACKGROUND: Indolent systemic mastocytosis (ISM) is a disease characterised by the accumulation and activation of mast cells. Symptoms are diverse and range from mild to severely debilitating or even fatal. It is considered rare but is underdiagnosed due to lack of awareness. Quantitative studies have shown that ISM can negatively impact quality of life. No qualitative studies have described everyday life with the disease.
DESIGN: A qualitative interview study taking a phenomenological approach.
METHODS: Seven qualitative, semi-structured interviews with adult patients with ISM. The analysis was inspired by Giorgi's phenomenological method. COREQ reporting guidelines were used.
RESULTS: Three themes and five subthemes emerged from the analysis. (a) The everyday life with a rare disease, unknown to most people. Being perceived as a hypochondriac in the encounter with the health system. The diagnosis makes a difference. Expert knowledge is important. (b) Living with and handling the invisible and visible symptoms. The visible body. (c) Fearing an attack. Feeling safe and vulnerable at the same time.
CONCLUSION: Patients with ISM are severely affected in their everyday lives, especially in terms of their relationship with family and social network. Symptoms restrict and complicate activities and participation in social contexts, and the fear of an anaphylactic attack is always present. The disease affects patients' self-perception and sexuality. The rarity of the disease and general low awareness seems to be of great importance in the encounter with the healthcare system, both before and after diagnosis, and there is a need for expert knowledge, support and care. RELEVANCE FOR CLINICAL PRACTICE: The focus of counselling should not only be on the disease itself, but also on living life with the disease.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic rare disease; counselling; disease management; everyday life; health personnel; nursing; patient experience; patient perspectives; qualitative research; systemic mastocytosis

Mesh:

Year:  2018        PMID: 30230078     DOI: 10.1111/jocn.14676

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  3 in total

Review 1.  Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.

Authors:  Ester Di Agosta; Lorenzo Salvati; Monica Corazza; Ilaria Baiardini; Francesca Ambrogio; Luisa Angileri; Elettra Antonelli; Federica Belluzzo; Domenico Bonamonte; Laura Bonzano; Raffaele Brancaccio; Paolo Custurone; Aurora De Marco; Aikaterini Detoraki; Adriana Di Guida; Elisabetta Di Leo; Marta Fantò; Filippo Fassio; Silvia Mariel Ferrucci; Caterina Foti; Rosella Gallo; Alessia Gatta; Fabrizio Guarneri; Lucia Guidolin; Katharina Hansel; Donatella Lamacchia; Carla Lombardo; Paola Lucia Minciullo; Maddalena Napolitano; Alessandro Pannofino; Andrea Paravisi; Roberta Parente; Maria Passante; Cataldo Patruno; Diego Peroni; Cristina Quecchia; Natale Schettini; Giuseppe Spadaro; Luca Stingeni; Daniele Tarrini; Marta Tramontana; Eustachio Nettis; Oliviero Rossi
Journal:  Clin Mol Allergy       Date:  2021-12-20

2.  The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity.

Authors:  Polina Pyatilova; Tameem Ashry; Yanyan Luo; Jiajun He; Hanna Bonnekoh; Qingqing Jiao; Sherezade Moñino-Romero; Man Hu; Jörg Scheffel; Stefan Frischbutter; Maud A W Hermans; Bradford A Youngblood; Marcus Maurer; Frank Siebenhaar; Pavel Kolkhir
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

3.  How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis.

Authors:  Kerstin Hamberg Levedahl; Annika Nilsson; Birgitta Johansson; Mariann Hedström
Journal:  Prim Health Care Res Dev       Date:  2022-09-07       Impact factor: 1.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.